<PAGE> 1
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
-------------
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No.)*
Antex Biologics Inc.
(Name of Issuer)
Common Stock
(Title of Class of Securities)
03672W-100
(CUSIP Number)
March 16, 2000
(Date of Event which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this
Schedule is filed:
|_| Rule 13d-1(b)
|X| Rule 13d-1(c)
|_| Rule 13d-1(d)
* The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would
alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not
be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section of
the Act, but shall be subject to all other provisions of the Act (however, see
the Notes).
Page 1 of 7
<PAGE> 2
(CUSIP No.) 03672W-100 Page 2 of 7 Pages
- ----------- --------------------------------------------------------------------
1
NAME OF REPORTING PERSON
S.S. Or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
First Lincoln Holdings, Inc. (I.D. # 95-2508211)
- ----------- --------------------------------------------------------------------
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) |_|
(b) |X|
- ----------- --------------------------------------------------------------------
3
SEC USE ONLY
- ----------- --------------------------------------------------------------------
4
CITIZENSHIP OR PLACE OF ORGANIZATION
Corporation organized under the law of the State of Delaware
- ------------------------------------------------ -------- ----------------------
Number of 5 SOLE VOTING POWER
Shares
Beneficially -0-
Owned By
Each Reporting
Person
With
-------- ----------------------
6 SHARED VOTING POWER
4,545,454 shares
-------- ----------------------
7 SOLE DISPOSITIVE POWER
-0-
-------- ----------------------
8 SHARED DISPOSITIVE
POWER
4,545,454 shares
- ----------- --------------------------------------------------------------------
9
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
4,545,454 shares
- ----------- --------------------------------------------------------------------
10
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES |_|
N/A
- ----------- --------------------------------------------------------------------
11
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
9.0
- ----------- --------------------------------------------------------------------
12
TYPE OF REPORTING PERSON*
CO
- ----------- --------------------------------------------------------------------
<PAGE> 3
(CUSIP No.) 03672W-100 Page 3 of 7 Pages
- ----------- --------------------------------------------------------------------
1
NAME OF REPORTING PERSON
S.S. Or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Marev Holdings, Inc. (I.D. # 51-1396121)
- ----------- --------------------------------------------------------------------
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) |_|
(b) |X|
- ----------- --------------------------------------------------------------------
3
SEC USE ONLY
- ----------- --------------------------------------------------------------------
4
CITIZENSHIP OR PLACE OF ORGANIZATION
Corporation organized under the law of the State of Delaware
- ------------------------------------------------ -------- ----------------------
Number of 5 SOLE VOTING POWER
Shares
Beneficially -0-
Owned By
Each Reporting
Person
With
-------- ----------------------
6 SHARED VOTING POWER
4,545,454 shares
-------- ----------------------
7 SOLE DISPOSITIVE POWER
-0-
-------- ----------------------
8 SHARED DISPOSITIVE
POWER
4,545,454 shares
- ----------- --------------------------------------------------------------------
9
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
4,545,454 shares
- ----------- --------------------------------------------------------------------
10
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES |_|
N/A
- ----------- --------------------------------------------------------------------
11
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
9.0
- ----------- --------------------------------------------------------------------
12
TYPE OF REPORTING PERSON*
CO
- ----------- --------------------------------------------------------------------
<PAGE> 4
(CUSIP No.) 03672W-100 Page 4 of 7 Pages
ITEM 1.
(a) Name of Issuer:
Antex Biologics Inc.
(b) Address of Issuer's Principal Executive Office:
3000 Professional Drive
Gaithersburg, MD 20879
ITEM 2.
(a) Name of Person Filing:
First Lincoln Holdings, Inc.
(b) Address of Principal Business Offices:
1001 Jefferson Plaza, Suite 200
Wilmington, DE 19801
(c) Citizenship:
Delaware, United States
(a) Name of Person Filing:
Marev Holdings, Inc.
(b) Address of Principal Business Offices:
1001 Jefferson Plaza, Suite 200
Wilmington, DE 19801
(c) Citizenship:
Delaware, United States
(d) Title of Class of Securities:
Common Stock, par value $.01 per share
(e) CUSIP Number:
03672W-100
ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO RULE 13d-1(b), OR
13d-2(b) OR (c), CHECK WHETHER THE PERSON FILING IS A:
Not Applicable.
ITEM 4. OWNERSHIP
First Lincoln Holdings, Inc.
(a) Amount beneficially owned: 4,545,454 shares
(b) Percent of Class: 9.0
(c) Number of Shares as to which such person has:
(i) sole power to vote or direct the vote: 0
(ii) shared power to vote or direct the vote:
4,545,454
(iii) sole power to dispose or direct the disposition
of: 0
(iv) shared power to dispose or direct the disposition
of: 4,545,454
<PAGE> 5
(CUSIP No.) 03672W-100 Page 5 of 7 Pages
Marev Holdings, Inc.
(a) Amount beneficially owned: 4,545,454 shares
(b) Percent of Class: 9.0
(c) Number of Shares as to which such person has:
(i) sole power to vote or direct the vote: 0
(ii) shared power to vote or direct the vote:
4,545,454
(iii) sole power to dispose or direct the disposition
of: 0
(iv) shared power to dispose or direct the disposition
of: 4,545,454
ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS:
Not Applicable.
ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON:
Not Applicable.
ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED
THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY OR
CONTROL PERSON:
Not Applicable.
ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP:
Not Applicable.
ITEM 9. NOTICE OF DISSOLUTION OF GROUP:
Not Applicable.
ITEM 10. CERTIFICATION:
By signing below I certify that, to the best of my knowledge
and belief, the securities referred to above were not acquired and are not held
for the purpose of or with the effect of changing or influencing the control of
the issuer of the securities and were not acquired and are not held in
connection with or as a participant in any transaction having that purpose or
effect.
<PAGE> 6
(CUSIP No.) 03672W-100 Page 6 of 7 Pages
After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this Statement is true,
complete and correct.
Dated: March 27, 2000 FIRST LINCOLN HOLDINGS, INC., a
Delaware corporation
By /s/ David M. Taylor
David M. Taylor, Treasurer
MAREV HOLDINGS, INC., a
Delaware corporation
By /s/ David M. Taylor
David M. Taylor, Secretary
<PAGE> 7
(CUSIP No.) 03672W-100 Page 7 of 7 Pages
It is hereby agreed, pursuant to Securities Exchange Act Rule
13d-1(k)(iii), that the foregoing Schedule 13G is filed on behalf of each of the
undersigned entities.
FIRST LINCOLN HOLDINGS, INC.
By /s/ David M. Taylor
David M. Taylor, Treasurer
MAREV HOLDINGS, INC.
By /s/ David M. Taylor
David M. Taylor, Secretary
